- Home
- DAVA vs NRC Comparison
DAVA vs NRC Comparison
Compare DAVA & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAVA | NRC |
|---|---|---|
| Founded | 2000 | 1981 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 365.7M | 428.2M |
| IPO Year | 2015 | 1997 |
Fundamental Metrics
Financial Performance| Metric | DAVA | NRC |
|---|---|---|
| Price | $5.31 | $13.21 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $14.57 | N/A |
| AVG Volume (30 Days) | ★ 528.3K | 131.3K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.78% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $119,686,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.26 | N/A |
| P/E Ratio | ★ $20.02 | $31.14 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $4.38 | $9.76 |
| 52 Week High | $23.71 | $22.79 |
Technical Indicators
Market Signals| Indicator | DAVA | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 49.49 | 39.09 |
| Support Level | $4.85 | $12.74 |
| Resistance Level | $7.04 | $14.20 |
| Average True Range (ATR) | 0.39 | 0.85 |
| MACD | 0.06 | 0.22 |
| Stochastic Oscillator | 67.52 | 54.23 |
Price Performance
Historical ComparisonAbout DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.